EORTC QLQ-C30 subgroup results confirm broad and durable quality-of-life improvements across disease stages and metastasis status, complementing ...

These subgroup insights will guide trial design, patient selection, and endpoint strategy for Autonomix's upcoming U.S.-based multicenter clinical study, currently planned to begin in 2026, which will ...

A groundbreaking new study has found that a combination of two drugs can boost survival rates in prostate cancer patients by ...

MEN’S health issues, such as prostate and testicular cancer, make big headlines. But what gets less attention is why men are reluctant to seek help. They are less likely to see their GP than ...

As a seasoned explorer of all things wellness, from hidden Italian Alps retreats to the intricacies of blood glucose meters, ...

Let’s be honest, cancer is the uninvited guest who overstays their welcome. The older we get, the more likely they are to ...

The state’s annual vital statistics report and cancer report show some positive signs about lifespans, maternal health and ...

People with type 1 diabetes (previously called juvenile diabetes) are 4.29 times more likely to develop bladder cancer, ...

The FDA recently approved a pretzel-shaped implant that helps some bladder cancer patients keep their bladder. Dr. Chris ...

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...

Imagine a targeted approach to bladder cancer that spares healthy cells while delivering chemotherapy directly to cancerous ones, offering hope for patients with advanced stages of the disease.